Skip to content

   Pharma Publications

Neuropsychopharmacology
  • The National Institute on Drug Abuse Summer Research Internship Program: Building a Diverse National Scientific Workforce
    Published on 2022-07-28
    3 years ago
  • Blood-based biomarkers for suicide in depression: moving a step closer to prediction
    Published on 2022-07-26
    3 years ago
  • How much is too much? New evidence associating low levels of prenatal alcohol exposure with brain differences in children
    Published on 2022-07-26
    3 years ago
  • Synaptic plasticity of the orbitofrontal cortex in obesity
    Published on 2022-07-26
    3 years ago
  • A highly D3R-selective and efficacious partial agonist (S)-ABS01-113 compared to its D3R-selective antagonist enantiomer (R)-ABS01-113 as potential treatments for opioid use disorder
    Published on 2022-07-25
    3 years ago
  • Medial septum activation improves strategy switching once strategies are well-learned via bidirectional regulation of dopamine neuron population activity
    Published on 2022-07-23
    3 years ago
  • Reaching for the unreachable: low intensity focused ultrasound for non-invasive deep brain stimulation
    Published on 2022-07-22
    3 years ago
« Previous 1 … 127 128 129 130 131 … 143 Next »
Journal of Psychopharmacology
  • Influence of covariates on heterogeneity in Hamilton Anxiety Scale ratings in placebo-controlled trials of benzodiazepines in generalized anxiety disorder: Systematic review and meta-analysis
    Published on 2019-01-24
    7 years ago
  • Psychiatrists’ reflections on a medication-free program for patients with psychosis
    Published on 2019-01-24
    7 years ago
  • Panicolytic-like effect of µ1-opioid receptor blockade in the inferior colliculus of prey threatened by Crotalus durissus terrificus pit vipers
    Published on 2019-01-21
    7 years ago
  • Dopamine manipulations drive changes in information sampling in healthy volunteers
    Published on 2019-01-15
    7 years ago
  • 3-Furan-2-yl-N-p-tolyl-acrylamide, a highly selective positive allosteric modulator of α7 nicotinic receptors, produces anxiolytic-like activity in mice
    Published on 2019-01-15
    7 years ago
  • Risk of readmission in patients with schizophrenia and schizoaffective disorder newly prescribed clozapine
    Published on 2019-01-08
    7 years ago
  • The pharmacological management of acute behavioural disturbance: Data from a clinical audit conducted in UK mental health services
    Published on 2018-12-19
    7 years ago
« Previous 1 … 127 128 129 130 131 … 134 Next »
European Neuropsychopharmacology
  • ECNP Calendar of Meetings
    Published on 2020-11-25
    5 years ago
  • P.796 Therapeutic management of young patients with schizoaffective disorder and alcohol use disorder dual diagnosis
    Published on 2020-11-25
    5 years ago
  • P.750 Impact of co-administration of 5-HT6 receptor ligands with haloperidol on MK-801-induced social impairments in rats
    Published on 2020-11-25
    5 years ago
  • P.815Endogenous neuropeptide cycloprolylglycine involves in regulation of HIF-1-dependent pathway
    Published on 2020-11-25
    5 years ago
  • Chronic nicotine, but not suramin or resveratrol, partially remediates the mania-like profile of dopamine transporter knockdown mice
    Published on 2020-11-25
    5 years ago
  • P.774 Olfactory reference syndrome as a prodrome of Alzheimer disease
    Published on 2020-11-25
    5 years ago
  • P.801Effect of 5-HT4 receptor agonism on memory processing during a functional MRI hippocampal task in humans
    Published on 2020-11-25
    5 years ago
« Previous 1 … 127 128 129 130 131 … 153 Next »

   Pharma Pub